Letter to the Editor
Efficacy and safety of baricitinib in patients with rheumatoid arthritis and inadequate response to conventional synthetic DMARDs and/or biological DMARDs: Data from a local registry
Eficacia y seguridad de baricitinib en pacientes con artritis reumatoide y respuesta inadecuada a FAME convencionales sintéticos o biológicos: datos de un registro local
Read
0
Timeswas read the article
0
Total PDF
0
Total HTML
0
Total EPUB
| Year/Month | Html | Epub | Total | |
|---|---|---|---|---|
| 2021 April | 0 | 0 | 0 | 0 |
| 2021 March | 0 | 0 | 0 | 0 |
| 2021 February | 0 | 0 | 0 | 0 |
| 2021 January | 0 | 0 | 0 | 0 |
| 2020 December | 0 | 0 | 0 | 0 |
